Research / CL / Fundamental state Inspectable configuration
State dimensions Filing 0000021665-23-000007 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
48.73% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.87% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.23% · OPTIONAL · VALID
Revenue growth 56th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
3.13% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.54% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
57.04% · CORE · VALID
Operating margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.10% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.78% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.70% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 37 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 184.78%
Current 48.73%
Delta -136.05% Capex Intensity Decreased
Previous 3.93%
Current 3.87%
Delta -0.05% Cash Generation Decreased
Previous 21.75%
Current 14.23%
Delta -7.52% Growth Increased
Previous 0.93%
Current 3.13%
Delta 2.21% Inventory Pressure Decreased
Previous 46.53%
Current 11.54%
Delta -34.99% Margin Decreased
Previous 57.19%
Current 57.04%
Delta -0.16% Profitability Decreased
Previous 21.26%
Current 16.10%
Delta -5.16% Sbc Intensity Decreased
Previous 1.35%
Current 0.70%
Delta -0.65% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.